Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Redaelli

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Endocrine-Related Cancer|January 20, 2018
Novel targeted therapeutics for MEN2Sara Redaelli, Ivan Plaza-Menacho, Luca Mologni
Cancers|January 6, 2021
Dual Kinase Targeting in LeukemiaLuca Mologni, Giovanni Marzaro, Sara Redaelli, et al.
The International Journal of Oral & Maxillofacial Implants|December 31, 2003
Four-year follow-up of larger-diameter implants placed in fresh extraction sockets using a resorbable membrane or a resorbable alloplastic materialLoris Prosper, Enrico F Gherlone, Sara Redaelli, et al.
Molecular and Cellular Endocrinology|July 2, 2013
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinaseLuca Mologni, Sara Redaelli, Andrea Morandi, et al.
The International Journal of Oral & Maxillofacial Implants|June 5, 2009
A randomized prospective multicenter trial evaluating the platform-switching technique for the prevention of postrestorative crestal bone lossLoris Prosper, Sara Redaelli, Massimo Pasi, et al.
Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs|June 18, 2016
Daily nursing care on patients undergoing venous-venous extracorporeal membrane oxygenation: a challenging procedure!Sara Redaelli, Alberto Zanella, Manuela Milan, et al.
Nucleic Acids Research|May 10, 2012
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discoveryRocco Piazza, Alessandra Pirola, Roberta Spinelli, et al.
Oncotarget|September 24, 2016
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphomaSara Redaelli, Monica Ceccon, Laura Antolini, et al.
Molecular Genetics & Genomic Medicine|February 6, 2014
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseasesRoberta Spinelli, Alessandra Pirola, Sara Redaelli, et al.
The Analyst|January 17, 2013
Rapid recognition of drug-resistance/sensitivity in leukemic cells by Fourier transform infrared microspectroscopy and unsupervised hierarchical cluster analysisGiuseppe Bellisola, Gianfelice Cinque, Marzia Vezzalini, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Endocrine-Related Cancer|January 20, 2018
Novel targeted therapeutics for MEN2Sara Redaelli, Ivan Plaza-Menacho, Luca Mologni
Cancers|January 6, 2021
Dual Kinase Targeting in LeukemiaLuca Mologni, Giovanni Marzaro, Sara Redaelli, et al.
The International Journal of Oral & Maxillofacial Implants|December 31, 2003
Four-year follow-up of larger-diameter implants placed in fresh extraction sockets using a resorbable membrane or a resorbable alloplastic materialLoris Prosper, Enrico F Gherlone, Sara Redaelli, et al.
Molecular and Cellular Endocrinology|July 2, 2013
Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinaseLuca Mologni, Sara Redaelli, Andrea Morandi, et al.
The International Journal of Oral & Maxillofacial Implants|June 5, 2009
A randomized prospective multicenter trial evaluating the platform-switching technique for the prevention of postrestorative crestal bone lossLoris Prosper, Sara Redaelli, Massimo Pasi, et al.
Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs|June 18, 2016
Daily nursing care on patients undergoing venous-venous extracorporeal membrane oxygenation: a challenging procedure!Sara Redaelli, Alberto Zanella, Manuela Milan, et al.
Nucleic Acids Research|May 10, 2012
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discoveryRocco Piazza, Alessandra Pirola, Roberta Spinelli, et al.
Oncotarget|September 24, 2016
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphomaSara Redaelli, Monica Ceccon, Laura Antolini, et al.
Molecular Genetics & Genomic Medicine|February 6, 2014
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseasesRoberta Spinelli, Alessandra Pirola, Sara Redaelli, et al.
The Analyst|January 17, 2013
Rapid recognition of drug-resistance/sensitivity in leukemic cells by Fourier transform infrared microspectroscopy and unsupervised hierarchical cluster analysisGiuseppe Bellisola, Gianfelice Cinque, Marzia Vezzalini, et al.
Pageof 4